Anthropic's Long-Term Benefit Trust appoints Vas Narasimhan to its Board of Directors

Our Long-Term Benefit Trust has appointed Vas Narasimhan to Anthropic's Board of Directors.

Anthropic's Long-Term Benefit Trust has appointed Vas Narasimhan to Anthropic's Board of Directors. The post discloses only that he has 20+ years in medicine and global health and served as Novartis CEO; term length, scope, and effective date are not disclosed. The key signal is board shaping through Anthropic's trust structure, this time adding a pharma and global health profile.

Why it matters: This is a real Anthropic governance change; the key signal is LTBT exercising board influence, not just the bio. HKR-K and HKR-R pass, but HKR-H is weaker because the post omits term, remit, and strategic context, so it lands at the low end of featured.